Fig. 4: The diagnostic value of metabolite levels after treatment for poor outcomes in mut-MMA.
From: Long-term follow-up of Chinese patients with methylmalonic acidemia of the cblC and mut subtypes
ROC curve of four diagnostic metabolites for the diagnosis of poor outcomes (a), abnormal neuropsychological test results (b), motor disturbance (c), anemia (d), neurologic disorders (e) and abnormal MRI results (f) in mut-MMA.
